BioCentury
ARTICLE | Company News

MorphoSys deal

March 5, 2012 8:00 AM UTC

MorphoSys granted an undisclosed biopharmaceutical company non-exclusive, worldwide rights to MorphoSys' Slonomics-based DNA libraries. MorphoSys will receive annual funding under the three-year deal, and is eligible for milestones and royalties. Details were not disclosed. ...